| 英文品名 |
ganitumab |
| 名称来源 |
p-INNList-103,2010; ; |
| 化学表述 |
immunoglobulin G1-kappa, anti-[Homo sapiens IGF1R (insulin-likegrowth factor 1 receptor, IGF1-R, IGF-1R, CD221)], Homo sapiensmonoclonal antibody;gamma1 heavy chain (1-449) [Homo sapiens VH (IGHV4-4*02(100.00%) -(IGHD)-IGHJ3*02) [9.7.12] (1-119) -IGHG1*01 (120-449)], (222-219')-disulfide with kappa light chain (1'-219') [Homosapiens V-KAPPA (IGKV2-28*01 (95.00%) -IGKJ1*01) [11.3.9] (1'-112') -IGKC*01 (113'-219')]; (228-228'':231-231'')-bisdisulfide dimer |
| CA登记号 |
905703-97-1 |
| 结 构 式 |
|
| 品种类别 |
antineoplastic; |
|
